Generic Pharmasec is currently trading at Rs. 9.14, up by 0.05 points or 0.55% from its previous closing of Rs. 9.09 on the BSE.
The scrip opened at Rs. 9.22 and has touched a high and low of Rs. 9.30 and Rs. 9.05 respectively. So far 109660 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 14.02 on 14-Oct-2020 and a 52 week low of Rs. 7.11 on 03-May-2021.
Last one week high and low of the scrip stood at Rs. 9.49 and Rs. 9.02 respectively. The current market cap of the company is Rs. 253.05 crore.
The promoters holding in the company stood at 59.96% and Non-Institutions held 40.04%.
Generic Pharmasec has successfully executed an order from Reliance Group for upgrading Point of Care Diagnostics by installing Abbot Point of Care I-Stat Blood Analysers at their group hospitals namely, Sir H. N. Reliance Hospital at Mumbai, Reliance Foundation Hospital at Jamnagar, Reliance Industries Hospitals at Bharuch and at Surat.
The company is in dialogue with Reliance Group for further orders and implementation for their Group hospitals at various other locations.
Generic Pharmasec will now increase its focus on creating high value propositions for all hospitals in India for all their Critical Diagnostic Requirements. To Increase the footprint in the country & improve access to Critical Diagnostic Solutions in Tier-2 & Tier-3 towns, Generic Pharmasec will appoint 15 new sub-distributors over the course of the next 24 months in such identified towns across the country.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: